Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:2
  • preuzimanja u poslednjih 30 dana:0

Sadržaj

članak: 3 od 6  
Back povratak na rezultate
2015, vol. 54, br. 2, str. 56-62
Uticaj izabranog ljekara na obuhvat MMR vakcinom
aInstitute for Public Health Podgorica, Montenegro
bPublic Health Institute, Niš

e-adresadragan.lausevic@ijzcg.me
Ključne reči: morbili; rubela; MMR; obuhvat primoimunizacijom; izabrani doktor
Sažetak
U evropskom regionu Svetske zdravstvene organizacije u toku je proces eliminacije malih boginja (morbila) i rubele, odnosno kongenitalnog rubela sindroma - KRS. Da bi se sproveo proces eliminacije navedenih oboljenja, neophodno je postići obuhvat obveznika imunizacijom protiv malih boginja sa dvije doze i rubelom sa jednom dozom od najmanje 95%. Pretpostavka je da na procenat obuhvata primoimunizacije MMR-om može uticati to da li obveznik ima izabranog doktora. U toku jula i avgusta 2014. godine sprovedena je studija presjeka kojom su prikupljeni podaci o primoimunizaciji MMR vakcinom za sve obveznike vakcinacije rođene od 01. januara 2008. do 31. decembra 2012. godine. Istovremeno, prikupljeni su i podaci o tome da li obveznici imaju izabranog doktora ili ne. Obrađeno je 40938 djece rođene od 01. januara 2008. do 31. decembra 2012. godine koja se nalaze u registru obveznika za imunizaciju. Ukupan obuhvat za obveznike navedenog uzrasta u trenutku sprovođenja analize iznosio je 94,1%, pri čemu je za obveznike sa izabranim doktorom (39471) 96,3%, a obveznike bez izabranog doktora (1474) 34,1%, što predstavlja visoko statistički značajnu razliku. Trenutno, učešće obveznika bez izabranog doktora u ukupnom broju obveznika iz analiziranih kohorti na nivou države iznosi 3,6%, uz variranje na nivou pojedinih opština, koje se kreće u rasponu od 0,7% do 7,4%. Rezultati studije jasno ukazuju da su obveznici koji imaju izabrane doktore u značajno većom obimu primoimunizovani MMR vakcinom od obveznika koji nemaju izabranog doktora. Neophodno je sprovesti aktivnosti kako bi se broj lica, obveznika za imunizaciju, sveo na vrijednost ispod 1% od ukupnog broja obveznika, kao i dopunske aktivnosti, koje podrazumevaju pozivanja i vakcinaciju obveznika koji nemaju izabranog doktora.
Reference
*** Strategic plan for measles and congenital rubella infection in the European region of WHO. Copenhagen, http://www.euro.who.int/_data/assets/pdf_file/0020/79022/E81567.pdf
*** (2005) Eliminating measles and rubella and preventing congenital rubella infection. u: WHO European Region strategic plan 2005-2010, Copenhagen: WHO Regional Office for Europe, 2014 Dec., http://www.euro.who.int/document/E87772.pdf
*** (2005) WHO regional committee for Europe resolution EUR/RC55/R7 on strengthening national immunization systems through measles and rubella elimination and prevention of congenital rubella infection in WHO’s European Region. Copenhagen: WHO Regional Office for Europe, http://www.euro.who.int/data/assets/pdf_file/0003/88086/RC55_eres07.pdf
*** (2010) WHO regional committee for Europe resolution EUR/RC60/R12 on renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and sustained support for polio-free status in the WHO European Region. Copenhagen: WHO Regional Office for Europe, http://www.euro.who.int/data/assets/pdf_file/0016/122236/RC60_eRes12.pdf
*** (2013) Framework for verifying elimination of measles and rubella. Relevé épidémiologique hebdomadaire, 88(9): 89-99
*** (2010) Ordinance on the conditions and manner of conducting the compulsory immunoprophylaxis and haemoprophylaxis against certain infectious diseases. Official Gazette of Montenegro, Podgorica, Montenegro, No. 31
Bardenheier, B., Yusuf, H., Schwartz, B., Gust, D., Barker, L., Rodewald, L. (2004) Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?. Archives of pediatrics & adolescent medicine, 158(6): 569-75
Briss, P.A., Rodewald, L.E., Hinman, A.R., Shefer, A.M., Strikas, R.A., Bernier, R.R., Carande-Kulis, V.G., Yusuf, H.R., Ndiaye, S.M., Williams, S.M. (2000) Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults11The names and affiliations of the Task Force members are listed on page v of this supplement and at http://www.thecommunityguide.org22So. American Journal of Preventive Medicine, 18(1): 97-140
Campos-Outcalt, D., Jeffcott-Pera, M., Carter-Smith, P., Schoof, B.K., Young, H.F. (2010) Vaccines Provided by Family Physicians. Annals of Family Medicine, 8(6): 507-510
Henderson, D.A. (1991) The Measles Epidemic. JAMA, 266(11): 1547
Institute for public health-Centre for disease control and prevention (2014) Annual report on immunizationsn 2013. May
Institute for public health-Centre for disease control and prevention (2010) Annual report on immunizations 2009. May
Institute for public health-Centre for disease control and prevention (2011) Annual report on immunizations 2010. May
Institute for public health-Centre for disease control and prevention (2012) Annual report on immunizations 2011. May
Institute for public health-Centre for disease control and prevention (2013) Annual report on immunizations 2012. May
Irigoyen, M.M., Findley, S., Earle, B., Stambaugh, K., Vaughan, R. (2000) Impact of appointment reminders on vaccination coverage at an urban clinic. Pediatrics, 106(4), 919-23
Omer, S.B., Salmon, D.A., Orenstein, W.A., de Hart, M. P., Halsey, N. (2009) Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable Diseases. New England Journal of Medicine, 360(19): 1981-1988
Orenstein, W.A., Strebel, P.M., Papania, M., Sutter, R.W., Bellini, W.J., Cochi, S.L. (2000) Measles eradication: is it in our future?. American journal of public health, 90(10): 1521-5
Petousis-Harris, H., Goodyear-Smith, F., Turner, N., Soe, B. (2004) Family physician perspectives on barriers to childhood immunisation. Vaccine, 22(17-18): 2340-2344
Romain, S., Schillaci, M.A. (2009) Childhood immunization: Availability of primary care providers in Ontario. Can Fam Physician, 55(11), 1104-05, e4
Smith, M.J., Ellenberg, S.S., Bell, L.M., Rubin, D.M. (2008) Media Coverage of the Measles-Mumps-Rubella Vaccine and Autism Controversy and Its Relationship to MMR Immunization Rates in the United States. Pediatrics, 121(4): e836-e843
Smith, P.J., Kennedy, A.M., Wooten, K., Gust, D.A., Pickering, L.K. (2006) Association between health care providers influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics, 118, str. 1287-1292
Spika, John S., Wassilak, S., Pebody, R., Lipskaya, G., Deshevoi, S., Güriş, D., Emiroglu, N. (2003) Measles and Rubella in the World Health Organization European Region: Diversity Creates Challenges. Journal of Infectious Diseases, 187(s1): S191-S197
Statistical office of Montenegro-Monstat (2011) Statistical yearbook 2010. Podgorica
Statistical office of Montenegro-Monstat (2012) Statistical yearbook 2011. Podgorica
Statistical office of Montenegro-Monstat (2013) Statistical yearbook 2012. Podgorica
Statistical office of Montenegro-Monstat (2009) Statistical yearbook 2008. Podgorica
Statistical office of Montenegro-Monstat (2010) Statistical yearbook 2009. Podgorica
Theeten, H., Hens, N., Vandermeulen, C., Depoorter, A., Roelants, M., Aerts, M., Hoppenbrouwers, K., van Damme, P. (2007) Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-survey. Vaccine, 25(26): 4940-4948
 

O članku

jezik rada: engleski
vrsta rada: pregledni članak
DOI: 10.5633/amm.2015.0210
objavljen u SCIndeksu: 03.04.2016.

Povezani članci